Clonal Multipotency of Skeletal Muscle-Derived Stem Cells Between Mesodermal and Ectodermal Lineage

Authors

  • Tetsuro Tamaki Ph.D.,

    Corresponding author
    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Department of Regenerative Medicine, Division of Basic Clinical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    • Muscle Physiology and Cell Biology Unit, Department of Regenerative Medicine, Division of Basic Clinical Science, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1143, Japan. Telephone: +81-463-93-1121 (ext. 2524); Fax: +81-463-95-0961
    Search for more papers by this author
  • Yoshinori Okada,

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Teaching & Research Support Center, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author
  • Yoshiyasu Uchiyama,

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Department of Orthopedics, Division of Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author
  • Kayoko Tono,

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Department of Regenerative Medicine, Division of Basic Clinical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author
  • Maki Masuda,

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Department of Regenerative Medicine, Division of Basic Clinical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author
  • Mika Wada,

    1. Department of Regenerative Medicine, Division of Basic Clinical Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author
  • Akio Hoshi,

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Department of Urology, Division of Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author
  • Tetsuya Ishikawa,

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Stem Cell Research, Research Center Japan, Nihon Schering KK, Chuo-ku, Kobe, Japan
    Search for more papers by this author
  • Akira Akatsuka

    1. Muscle Physiology & Cell Biology Unit, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    2. Teaching & Research Support Center, Tokai University School of Medicine, Isehara, Kanagawa, Japan
    Search for more papers by this author

Abstract

The differentiation potential of skeletal muscle-derived stem cells (MDSCs) after in vitro culture and in vivo transplantation has been extensively studied. However, the clonal multipotency of MDSCs has yet to be fully determined. Here, we show that single skeletal muscle-derived CD34/CD45 (skeletal muscle-derived double negative [Sk-DN]) cells exhibit clonal multipotency that can give rise to myogenic, vasculogenic, and neural cell lineages after in vivo single cell-derived single sphere implantation and in vitro clonal single cell culture. Muscles from green fluorescent protein (GFP) transgenic mice were enzymatically dissociated and sorted based on CD34 and CD45. Sk-DN cells were clone-sorted into a 96-well plate and were cultured in collagen-based medium with basic fibroblast growth factor and epidermal growth factor for 14 days. Individual colony-forming units (CFUs) were then transplanted directly into severely damaged muscle together with 1 × 105 competitive carrier Sk-DN cells obtained from wild-type mice muscle expanded for 5 days under the same culture conditions using 35-mm culture dishes. Four weeks after transplantation, implanted GFP+ cells demonstrated differentiation into endothelial, vascular smooth muscle, skeletal muscle, and neural cell (Schwann cell) lineages. This multipotency was also confirmed by expression of mRNA markers for myogenic (MyoD, myf5), neural (Musashi-1, Nestin, neural cell adhesion molecule-1, peripheral myelin protein-22, Nucleostemin), and vascular (α-smooth muscle actin, smoothelin, vascular endothelial-cadherin, tyrosine kinase-endothelial) stem cells by clonal (single-cell derived) single-sphere reverse transcription-polymerase chain reaction. Approximately 70% of clonal CFUs exhibited expression of all three cell lineages. These findings support the notion that Sk-DN cells are a useful tool for damaged muscle-related tissue reconstitution by synchronized vasculogenesis, myogenesis, and neurogenesis.

Disclosure of potential conflicts of interest is found at the end of this article.

Ancillary